3M’s healthcare spinoff Solventum has been completed and began publicly trading on the New York Stock Exchange (NYSE) on April 1 under the ticker symbol "SOLV."
Solventum consists of these segments: dental, medical surgical, health information systems, and purification and filtration. The dental segment offers brackets, aligners, cements, bonding agents, as well as products for preventive care and direct and indirect restorations.
While part of 3M in 2023, the Solventum business had sales of $8.2 billion. Solventum has 22,000 employees and is led by CEO Bryan Hanson, Chief Financial Officer Wayde McMillan, and Board Chair Carrie Cox. The leadership are scheduled to ring the opening bell at the NYSE on April 3.
